Redcare Pharmacy (SAEYY)

Tuesday

2:09 PM

ThesisIncreased competition from online pharmacies and regulatory pressures are raising concerns about Redcare's ability to maintain its market position and profitability.

Revenue Outlook

Metric	FY2025	FY2026E	FY2027E
Revenue	$2.8B	$3.4B	$3.8B
Rev. Growth	+19.2%	+21.3%	+11.8%
EPS	$-0.18	$0.00	$0.00
EPS Growth	+21.7%	+100%	—
P/E	—	—	—

★ Analysts see FY2026 revenue reaching $3.4B — +21.3% growth in a single year.

Why Revenue Could Accelerate

01Redcare has secured a new multi-year contract with a leading healthcare provider, expected to increase revenue by 15% annually.
02The company is implementing a new logistics software that could reduce delivery times by 20%, enhancing customer satisfaction.
03Recent regulatory changes in the EU are expected to favor established distributors like Redcare, potentially increasing market share.
04Digital transformation in healthcare distribution
05Increased focus on patient-centric healthcare solutions
06Changes in pharmaceutical regulations in Europe
07Fluctuations in drug pricing and reimbursement rates
08Partnership agreements with major healthcare providers

FY2025 Snapshot

Revenue: $2.8B
Rev. Growth: +19.2%
Gross Margin: 20.2%
Op. Margin: -0.8%
Net Margin: -1.3%
Net Income: $-36M
NI Growth: +20.3%
EPS: $-0.18
1Y Return: -23.6%

My Notes

"The market is reacting to potential headwinds that could impact our growth trajectory."
Moat: Redcare's competitive advantage lies in its established logistics network and strong relationships with healthcare providers.
value - Investors may be drawn to Redcare due to its low price-to-sales ratio and potential for recovery in margins.
The company's debt levels may lead to increased financing costs if interest rates rise, potentially impacting profitability and cash flow.
Watch on earnings: Prescription medication sales growth, Gross margin trends, Operating cash flow trends.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $3.4B to $3.8B as redcare has secured a new multi-year contract with a leading healthcare provider.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research noteFirst read for a new ticker takes about 20-30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.